J.‐F. Yale
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Pancreatic function and diabetes, Diabetes and associated disorders, Diabetes, Cardiovascular Risks, and Lipoproteins
Most-Cited Works
- → Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease(2013)482 cited
- 1998 clinical practice guidelines for the management of diabetes in Canada(1998)
- → Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease(2014)272 cited
- → A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose‐lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study(2006)195 cited
- → Effect of acarbose on insulin sensitivity in elderly patients with diabetes.(2000)137 cited
- → Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice(2012)114 cited
- → Acarbose in the treatment of elderly patients with type 2 diabetes(2002)111 cited
- → Oral Antihyperglycemic Agents and Renal Disease(2005)81 cited
- → Effects of Cyclosporine on Glucose Tolerance in the Rat(1985)71 cited
- → The prediction of resting energy expenditure in type 2 diabetes mellitus is improved by factoring for glycemia(2002)60 cited